Literature DB >> 15790594

Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease.

Dermot P B McGovern1, Pirro Hysi, Tariq Ahmad, David A van Heel, Miriam F Moffatt, Alisoun Carey, William O C Cookson, Derek P Jewell.   

Abstract

The identification of the role of genetic variants within NOD2 (CARD15) in Crohn's disease and ulcerative colitis susceptibility highlight the role of the innate immune system in inflammatory bowel disease (IBD) pathogenesis. NOD1 (CARD4) is located on chromosome 7p14.3, in a region of known linkage to IBD and encodes an intracellular bacterial pathogen-associated molecular pattern receptor that is closely related to NOD2. We have identified strong association between haplotypes in the terminal exons of NOD1 and IBD (multi-allelic P = 0.0000003) in a panel of 556 IBD trios. The deletion allele of a complex functional NOD1 indel polymorphism (ND(1) + 32656*1) was significantly associated with early-onset IBD (P = 0.0003) in unrelated cases and controls. ND1 + 32656*1 was also associated with extra-intestinal manifestations of IBD (P = 0.04). These findings in two independent populations provide strong evidence for a role for NOD1 variants in IBD susceptibility and reinforce the role of the innate immune system in IBD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790594     DOI: 10.1093/hmg/ddi135

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  96 in total

Review 1.  Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals.

Authors:  Ling Zhao; Joo Y Lee; Daniel H Hwang
Journal:  Nutr Rev       Date:  2011-06       Impact factor: 7.110

Review 2.  Effector functions of NLRs in the intestine: innate sensing, cell death, and disease.

Authors:  Garabet Yeretssian
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 3.  Expression and functional importance of innate immune receptors by intestinal epithelial cells.

Authors:  Rute Marques; Ivo G Boneca
Journal:  Cell Mol Life Sci       Date:  2011-10-08       Impact factor: 9.261

Review 4.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

Review 5.  Novel susceptibility genes in inflammatory bowel disease.

Authors:  Colin Noble; Elaine Nimmo; Daniel Gaya; Richard K Russell; Jack Satsangi
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

Review 6.  TLRs in the Gut I. The role of TLRs/Nods in intestinal development and homeostasis.

Authors:  Ian R Sanderson; W Allan Walker
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-07-13       Impact factor: 4.052

7.  Purification, crystallization and preliminary crystallographic characterization of the caspase-recruitment domain of human Nod1.

Authors:  Thiagarajan Srimathi; Sheila L Robbins; Rachel L Dubas; Jang Hoon Seo; Young Chul Park
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-12-16

8.  No association between the functional CARD4 insertion/deletion polymorphism and inflammatory bowel diseases in the German population.

Authors:  A Franke; A Ruether; N Wedemeyer; T H Karlsen; A Nebel; S Schreiber
Journal:  Gut       Date:  2006-11       Impact factor: 23.059

9.  The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis.

Authors:  Grace Y Chen; Michael H Shaw; Gloria Redondo; Gabriel Núñez
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

10.  Impact of human pathogenic micro-insertions and micro-deletions on post-transcriptional regulation.

Authors:  Xinjun Zhang; Hai Lin; Huiying Zhao; Yangyang Hao; Matthew Mort; David N Cooper; Yaoqi Zhou; Yunlong Liu
Journal:  Hum Mol Genet       Date:  2014-01-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.